Evome Medical Technologies (Evome Medical Technologies) Earnings per Share (Diluted) : $-0.17 (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Evome Medical Technologies Earnings per Share (Diluted)?

Evome Medical Technologies's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $-0.16. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.17.

Evome Medical Technologies's EPS (Basic) for the three months ended in Dec. 2023 was $-0.16. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.17.

Evome Medical Technologies's EPS without NRI for the three months ended in Dec. 2023 was $-0.06. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.11.

During the past 3 years, the average EPS without NRIGrowth Rate was -43.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 1.00% per year.

During the past 11 years, Evome Medical Technologies's highest 3-Year average EPS without NRI Growth Rate was 38.80% per year. The lowest was -43.80% per year. And the median was 7.10% per year.

Evome Medical Technologies Earnings per Share (Diluted) Historical Data

The historical data trend for Evome Medical Technologies's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evome Medical Technologies Earnings per Share (Diluted) Chart

Evome Medical Technologies Annual Data

Trend

Dec14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Dec23

Earnings per Share (Diluted)

Get a 7-Day Free Trial

-0.02

-0.05

-0.08

-0.16

Evome Medical Technologies Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Mar23	Jun23	Sep23	Dec23
Earnings per Share (Diluted)	Get a 7-Day Free Trial															-0.02	-0.02	-0.02	0.02	-0.16

Competitive Comparison of Evome Medical Technologies's Earnings per Share (Diluted)

For the Medical Devices subindustry, Evome Medical Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Evome Medical Technologies's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Evome Medical Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where Evome Medical Technologies's PE Ratio falls into.

Evome Medical Technologies Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Evome Medical Technologies's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-11.63	-	0)	/	73.472
	=	-0.16

Evome Medical Technologies's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(-11.787	-	0)	/	79.890
	=	-0.15

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.17

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Evome Medical Technologies (OTCPK:LNDZF) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Evome Medical Technologies Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Evome Medical Technologies's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.